These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 17122267)
41. [Report of a case with huge Osborn waves]. Hoşcan Y; Ozgül M Anadolu Kardiyol Derg; 2006 Dec; 6(4):411-2. PubMed ID: 17162309 [No Abstract] [Full Text] [Related]
43. Coronary artery spasm as a frequent cause of acute coronary syndrome: The CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study. Ong P; Athanasiadis A; Hill S; Vogelsberg H; Voehringer M; Sechtem U J Am Coll Cardiol; 2008 Aug; 52(7):523-7. PubMed ID: 18687244 [TBL] [Abstract][Full Text] [Related]
44. The FDA droperidol warning: is it justified? Bailey P; Norton R; Karan S Anesthesiology; 2002 Jul; 97(1):288-9. PubMed ID: 12131147 [No Abstract] [Full Text] [Related]
45. Angioedema associated with droperidol administration. Palombaro JF; Klingelberger CE Ann Emerg Med; 1996 Mar; 27(3):379-81. PubMed ID: 8599504 [TBL] [Abstract][Full Text] [Related]
46. [Acute coronary syndrome due to coronary thrombus formed by severe coronary spasm: a case report]. Yamazaki K; Funayama N; Okabayashi H; Myojo T; Gima M; Tanaka H; Sakamoto N; Kikuchi K J Cardiol; 2007 Sep; 50(3):205-12. PubMed ID: 17941197 [TBL] [Abstract][Full Text] [Related]
47. In reply. Nuttall GA Anesthesiology; 2013 Sep; 119(3):730-1. PubMed ID: 23962938 [No Abstract] [Full Text] [Related]
48. Inapsine. Weighing the risk of fatal arrhythmias. Nursing; 2002 Mar; 32(3):26. PubMed ID: 11902037 [No Abstract] [Full Text] [Related]
49. FDA response to droperidol black box warning editorials. Rappaport BA Anesth Analg; 2008 May; 106(5):1585. PubMed ID: 18420886 [No Abstract] [Full Text] [Related]
51. Con: The black box warning on droperidol should not be removed (but should be clarified!). Ludwin DB; Shafer SL Anesth Analg; 2008 May; 106(5):1418-20. PubMed ID: 18420855 [No Abstract] [Full Text] [Related]
52. Pro: The Food and Drug Administration Black box warning on droperidol is not justified. Habib AS; Gan TJ Anesth Analg; 2008 May; 106(5):1414-7. PubMed ID: 18420854 [No Abstract] [Full Text] [Related]
54. Getting the word out. Turner C; Vu D CMAJ; 2003 Jan; 168(1):13, 16. PubMed ID: 12515776 [No Abstract] [Full Text] [Related]
55. Coronary spasm presenting as syncope during ventricular demand pacing. Hart TT; Kern MJ Am Heart J; 1986 Aug; 112(2):405-7. PubMed ID: 3739888 [No Abstract] [Full Text] [Related]
56. Electrocautery-induced ventricular tachycardia and fibrillation during device implantation and explantation. Lo R; Mitrache A; Quan W; Cohen TJ J Invasive Cardiol; 2007 Jan; 19(1):12-5. PubMed ID: 17297178 [TBL] [Abstract][Full Text] [Related]
57. Safety of patients reason for FDA black box warning on droperidol. Habib AS; Gan TJ Anesth Analg; 2004 Feb; 98(2):552. PubMed ID: 14742409 [No Abstract] [Full Text] [Related]
58. Black-box warning for droperidol surprises pharmacists. Young D Am J Health Syst Pharm; 2002 Mar; 59(6):494, 497, 502-4. PubMed ID: 11908241 [No Abstract] [Full Text] [Related]
59. Multivessel coronary artery spasm refractory to intensive medical treatment. Asano T; Kobayashi Y; Ohno M; Nakayama T; Kuroda N; Komuro I Angiology; 2007; 58(5):636-9. PubMed ID: 17906282 [TBL] [Abstract][Full Text] [Related]